Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Heart Failure × Endocrine × Clear all

Phase

Status

Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 18 Breast 7 Thoracic 6 Gastrointestinal 5 Classical hematology 5 Plasma cell 4 Other 4 Lymphoid 4 Head & Neck 4 Other hematologic neoplasm 2 NET 1 Myeloid 1 Endocrine 1 CNS 1

Conditions

Neuroendocrine Tumors 180 Multiple Endocrine Neoplasia Type 1 118 Thyroid Cancer, Papillary 69 Pituitary Neoplasms 59 Thyroid Neoplasms 47 Pheochromocytoma 46 Neoplasms 43 Carcinoma, Neuroendocrine 43 Carcinoid Tumor 36 Carcinoma, Medullary 33 Adrenocortical Carcinoma 29 Pancreatic Neoplasms 27 Adenocarcinoma, Follicular 27 Thyroid Carcinoma, Anaplastic 26 Insulinoma 25 Carcinoma, Non-Small-Cell Lung 24 Somatostatinoma 21 Colonic Neoplasms 21 Adenoma, Islet Cell 21 Neoplasm Metastasis 20 Colorectal Neoplasms 20 Carcinoma, Islet Cell 20 Breast Neoplasms 20 Adrenal Gland Neoplasms 20 Paraganglioma 19 Carcinoma, Renal Cell 19 Prostatic Neoplasms 18 Melanoma 18 Glucagonoma 18 Gastrinoma 18

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01730417 2012-11-21

mIBG

Duke University

Phase 1 Completed

Heart Failure, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡